Pharmacological ascorbate

DRUG3 trials

Sponsors

University of Iowa, Bryan Allen, William Zeitler

Conditions

AdenocarcinomaCancer of PancreasCancer of the PancreasGlioblastomaGlioblastoma MultiformeNeoplasms, PancreaticNon-small Cell Lung CancerPancreas Cancer

Phase 1

A Safety Study of Pharmacologic Ascorbate and Ferumoxytol in Addition to Standard of Care Chemoradiation in Glioblastoma

Active, not recruitingNCT04900792

Bryan AllenGlioblastoma, Glioblastoma Multiforme

Start: 2023-02-28End: 2026-12-31Updated: 2026-07-20

Ascorbate With Durvalumab in Non-Small Cell Lung Cancer (NSCLC)

TerminatedNCT06083454

William ZeitlerNon-small Cell Lung Cancer

Start: 2023-10-23End: 2026-01-09Updated: 2026-03-13

Phase 2

A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1)

CompletedNCT02905578

University of IowaAdenocarcinoma, Cancer of Pancreas, Cancer of the Pancreas +4

Start: 2018-11-28End: 2024-08-26Updated: 2026-07-23

Related Papers

A randomized trial of pharmacological ascorbate, gemcitabine, and nab-paclitaxel for metastatic pancreatic cancer.

2024-10-0214 citations

A phase II trial of pharmacological ascorbate, gemcitabine, and nabpaclitaxel for metastatic pancreatic cancer.

Journal of Clinical Oncology2020-02-01